home / stock / gnmk / gnmk quote
$19.34 Last:
4.15% Change Percent:
$18.56 Open:
$19.34 Previous Close:
$19.44 High:
$17.69 Low:
930,364 Volume:
03/05/2021 04:55:33 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-05 | 18.56 | 19.34 | 19.44 | 17.69 | 930,364 |
2021-03-04 | 18.86 | 18.57 | 19.66 | 18.121 | 1,312,354 |
2021-03-03 | 18.88 | 19.05 | 19.49 | 18.5 | 860,789 |
2021-03-02 | 19.09 | 18.94 | 20.126 | 18.87 | 791,789 |
2021-03-01 | 19.19 | 19.05 | 19.62 | 18.41 | 927,984 |
2021-02-26 | 17 | 19.55 | 19.88 | 16.904 | 1,966,682 |
2021-02-25 | 19.16 | 18.8 | 19.48 | 18.62 | 1,100,322 |
2021-02-24 | 19.12 | 19.29 | 19.69 | 19.08 | 573,893 |
2021-02-23 | 19.35 | 19.265 | 19.75 | 18.32 | 1,080,949 |
2021-02-22 | 20.36 | 19.82 | 20.77 | 19.51 | 881,733 |
2021-02-19 | 21.8 | 20.68 | 21.8 | 20.28 | 1,215,293 |
2021-02-18 | 21.63 | 21.66 | 22.28 | 21.32 | 498,782 |
2021-02-17 | 21.55 | 21.84 | 21.94 | 21.1148 | 778,626 |
2021-02-16 | 23.43 | 21.77 | 23.59 | 20.95 | 1,800,546 |
2021-02-15 | 21.55 | 22.74 | 22.8 | 21.18 | 1,694,087 |
2021-02-12 | 21.55 | 22.74 | 22.8 | 21.18 | 1,685,009 |
2021-02-11 | 19.27 | 22.45 | 23.49 | 19.1 | 7,778,643 |
2021-02-10 | 17 | 16.86 | 17.78 | 16.54 | 875,510 |
2021-02-09 | 14.73 | 16.86 | 17.72 | 14.67 | 2,756,928 |
2021-02-08 | 15 | 14.86 | 15.0906 | 14.37 | 1,007,956 |
GenMark Diagnostics Inc. Company Name:
GNMK Stock Symbol:
NASDAQ Market:
GenMark Diagnostics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
CARLSBAD, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fiscal year and quarter ended December 31, 2020. Full Year 20...
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that its ePlex Respiratory Pathogen Panel 2 (RP2) is predicted to detect known SARS-CoV-2 variants c...
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in th...